tert-Butyl 4-{4-[(Z)-N'-[(Z)-4-tert-butylbenzoyloxy]carbamimidoyl]phenyl}piperazine-1-carboxylate

Catalog No. :
ACAIZD839
CAS No. :
1273562-42-7
Molecular Formula :
C27H36N4O4
Molecular Weight :
480.61

IUPAC Name:tert-butyl (E)-4-(4-((2-((4-(tert-butyl)benzoyl)oxy)hydrazineylidene)methyl)phenyl)piperazine-1-carboxylate

tert-Butyl 4-{4-[(Z)-N'-[(Z)-4-tert-butylbenzoyloxy]carbamimidoyl]phenyl}piperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-{4-[(Z)-N'-[(Z)-4-tert-butylbenzoyloxy]carbamimidoyl]phenyl}piperazine-1-carboxylate
IUPAC Nametert-butyl (E)-4-(4-((2-((4-(tert-butyl)benzoyl)oxy)hydrazineylidene)methyl)phenyl)piperazine-1-carboxylate
Molecular FormulaC27H36N4O4
Molecular Weight480.61
SMILESCC(C)(C)OC(=O)N1CCN(C2=CC=C(/C=N/NOC(=O)C3=CC=C(C(C)(C)C)C=C3)C=C2)CC1
InChI KeyRLOIVCSAUAIFPB-TURZUDJPSA-N
Synonymtert-butyl 4-{4-[(Z)-N'-[(Z)-4-tert-butylbenzoyloxy]carbamimidoyl]phenyl}piperazine-1-carboxylate;1-Piperazinecarboxylic acid, 4-[4-[[[[4-(1,1-dimethylethyl)benzoyl]oxy]amino]iminomethyl]phenyl]-, 1,1-dimethylethyl ester
CAS No.1273562-42-7

Synthetic Route by SureRoute

1. ACAIZD839 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFADC710 route compound structure diagram
    ACFADC710197638-83-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAIZD839 route product structure diagram
    ACAIZD8391273562-42-7
Inquiry

2. ACAIZD839 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFADC710 route compound structure diagram
    ACFADC710197638-83-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAIZD839 route product structure diagram
    ACAIZD8391273562-42-7
Inquiry

Comments (0)